Loomans et al., demonstrated that loss of epithelial Activin receptor type IB (ACVRIB) increases aggressiveness in SCC, which correlates inversely with high stromal expression of INHBA suggesting that the receptor modulates the tumor suppression activity of this protein [56]. This evidence concerns the gene INHBA and neoplasm.